LE WE PMID CA
Immunopharmacology5165Immunpharmakologie

3 HMG CoA reductase

Adenosine

Autoimmunity

BG 12

BTLA

Cannabis

CD160

CD4

Chaperone

Cladribine

Complement system

Fingolimod

HVEM

Immunopharmacology

Interfering diseases

Laquinimod

LIGHT

MTOR

Multiple sclerosis

Mycobacterium (BASKET)

Natural products

Procyanidins

Receptor (Aromatic hydrocarbon)

Redox (BASKET)

RelB

Statin

Stem cell (BASKET)

T cell (gammadelta)

T cell (Th17)

Tamoxifen

Tannin

Teriflunomide

Vasoactive intestinal peptide

Vitamin D

2003  
1
Alerting and tuning the immune response by extracellular nucleotides.
[12629147] J Leukoc Biol 73(3): 339-43 (2003)
2002  
2
Treatments no longer in development for rheumatoid arthritis.
[12379620] Ann Rheum Dis 61 Suppl 2(-): ii43-5 (2002)
2007  
3
The use of stem cells for the treatment of autoimmune diseases.
[17713674] Braz J Med Biol Res 40(12): 1579-97 (2007)
2010  
4
Molecular chaperones and protein-folding catalysts as intercellular signaling regulators in immunity and inflammation.
[20445014] J Leukoc Biol 88(3): 445-62 (2010)
2010  
5
HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation.
[20007250] J Leukoc Biol 87(2): 223-35 (2010)
2003  
6
Specific CD4 down-modulating compounds with potent anti-HIV activity.
[12960237] J Leukoc Biol 74(5): 667-75 (2003)
2008  
7
Synthetic oligonucleotides as modulators of inflammation.
[18430787] J Leukoc Biol 84(4): 958-64 (2008)
2010  
8
The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease.
[19968663] Clin Exp Immunol 159(3): 256-67 (2010)
2009  
9
Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease.
[19604262] Clin Exp Immunol 157(2): 225-34 (2009)
2009  
10
Immunoregulatory functions of mTOR inhibition.
[19390566] Nat Rev Immunol 9(5): 324-37 (2009)
2009  
11
The adenosinergic immunomodulatory drugs.
[19539527] Curr Opin Pharmacol 9(4): 501-6 (2009)
2009  
12
Identification of novel immunosuppressive pathways paves the way for drug discovery.
[19625216] Curr Opin Pharmacol 9(4): 445-6 (2009)
2009  
13
Regulation of different inflammatory diseases by impacting the mevalonate pathway.
[19191903] Immunology 127(1): 18-25 (2009)
2009  
14
The aryl hydrocarbon receptor: a perspective on potential roles in the immune system.
[19538249] Immunology 127(3): 299-311 (2009)
2004  
15
Topical immunomodulators in dermatology.
[15235214] J Postgrad Med 50(2): 131-9 (2004)
2007  
16
Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: a paradigm for ligand-augmented negative transcriptional regulation.
[17367745] Arch Biochem Biophys 460(2): 218-26 (2007)
2011  
17
Development of oral immunomodulatory agents in the management of multiple sclerosis.
[21625416] Drug Des Devel Ther 5(-): 255-74 (2011)
2009  
18
The aryl hydrocarbon receptor is a modulator of anti-viral immunity.
[19027719] Biochem Pharmacol 77(4): 642-53 (2009)
2009  
19
AHR-mediated immunomodulation: the role of altered gene transcription.
[19100241] Biochem Pharmacol 77(4): 746-60 (2009)
2009  
20
The effects of tamoxifen on immunity.
[19689284] Curr Med Chem 16(24): 3076-80 (2009)
2010  
21
Do cannabinoids have a therapeutic role in transplantation?
[20591510] Trends Pharmacol Sci 31(8): 345-50 (2010)
2002  
22
Immune-based therapies: a review of clinical endpoints used in trials of selected immunologic agents.
[11819187] HIV Clin Trials 3(1): 58-88 (2002)
2008  
23
Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis.
[18177689] Semin Arthritis Rheum 38(3): 195-207 (2008)
2010  
24
The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.
[19959212] Gynecol Oncol 116(2): 222-33 (2010)
2010  
25
Mycobacteria-induced suppression of autoimmunity in the central nervous system.
[20333556] J Neuroimmune Pharmacol 5(2): 210-9 (2010)
2010  
26
Redox remodeling as an immunoregulatory strategy.
[20070126] Biochemistry 49(6): 1059-66 (2010)
2008  
27
Response of gammadelta T Cells to plant-derived tannins.
[19166386] Crit Rev Immunol 28(5): 377-402 (2008)
2009  
28
Recent developments in low molecular weight complement inhibitors.
[19800693] Mol Immunol 47(2-3): 185-95 (2009)
2011  
29
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells.
[21762539] J Biomed Sci 18(-): 49 (2011)
2007  
30
Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders.
[17521775] Peptides 28(9): 1833-46 (2007)
2008  
31
The immunopharmaceutical effects and mechanisms of herb medicine.
[18318991] Cell Mol Immunol 5(1): 23-31 (2008)
2010  
32
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.
[19457575] Immunobiology 215(8): 598-605 (2010)
2010  
33
Development of antibody surrogates for the treatment of cancers and autoimmune disease.
[20674470] Curr Opin Chem Biol 14(6): 721-7 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



  • Immunpharmakologie

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia